T. Rowe Price Associates’s Clorox CLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $18.6M | Sell |
179,955
-3,837
| -2% | -$435K | ﹤0.01% | 1063 |
|
|
2025
Q4 | $18.5M | Sell |
183,792
-1,822
| -1% | -$198K | ﹤0.01% | 1072 |
|
|
2025
Q3 | $22.9M | Buy |
185,614
+866
| +0.5% | +$107K | ﹤0.01% | 1032 |
|
|
2025
Q2 | $22.2M | Sell |
184,748
-141,196
| -43% | -$18.8M | ﹤0.01% | 939 |
|
|
2025
Q1 | $48M | Sell |
325,944
-228,744
| -41% | -$34.9M | 0.01% | 735 |
|
|
2024
Q4 | $90.1M | Buy |
554,688
+163,341
| +42% | +$26.7M | 0.01% | 585 |
|
|
2024
Q3 | $63.8M | Buy |
391,347
+216,005
| +123% | +$32M | 0.01% | 688 |
|
|
2024
Q2 | $23.9M | Buy |
175,342
+2,575
| +1% | +$358K | ﹤0.01% | 911 |
|
|
2024
Q1 | $26.5M | Sell |
172,767
-44,489
| -20% | -$6.64M | ﹤0.01% | 906 |
|
|
2023
Q4 | $31M | Buy |
217,256
+40,601
| +23% | +$5.41M | ﹤0.01% | 839 |
|
|
2023
Q3 | $23.2M | Sell |
176,655
-2,377
| -1% | -$361K | ﹤0.01% | 884 |
|
|
2023
Q2 | $28.5M | Sell |
179,032
-1,779
| -1% | -$287K | ﹤0.01% | 845 |
|
|
2023
Q1 | $28.6M | Buy |
180,811
+7,226
| +4% | +$1.08M | ﹤0.01% | 830 |
|
|
2022
Q4 | $24.4M | Sell |
173,585
-484
| -0.3% | -$68.7K | ﹤0.01% | 858 |
|
|
2022
Q3 | $22.4M | Sell |
174,069
-106,521
| -38% | -$15.4M | ﹤0.01% | 874 |
|
|
2022
Q2 | $39.6M | Buy |
280,590
+55,412
| +25% | +$7.92M | 0.01% | 955 |
|
|
2022
Q1 | $31.3M | Sell |
225,178
-25,692
| -10% | -$3.94M | ﹤0.01% | 1109 |
|
|
2021
Q4 | $43.7M | Sell |
250,870
-12,246
| -5% | -$2.04M | ﹤0.01% | 1054 |
|
|
2021
Q3 | $43.6M | Sell |
263,116
-26,069
| -9% | -$4.49M | ﹤0.01% | 1069 |
|
|
2021
Q2 | $52M | Sell |
289,185
-834,781
| -74% | -$152M | ﹤0.01% | 1014 |
|
|
2021
Q1 | $217M | Buy |
1,123,966
+96,332
| +9% | +$18.5M | 0.02% | 535 |
|
|
2020
Q4 | $208M | Buy |
1,027,634
+93,314
| +10% | +$19.3M | 0.02% | 523 |
|
|
2020
Q3 | $196M | Buy |
934,320
+333,692
| +56% | +$74.3M | 0.02% | 488 |
|
|
2020
Q2 | $132M | Buy |
600,628
+213,697
| +55% | +$42.7M | 0.02% | 564 |
|
|
2020
Q1 | $67M | Sell |
386,931
-15,480
| -4% | -$2.56M | 0.01% | 694 |
|
|
2019
Q4 | $61.8M | Sell |
402,411
-171,565
| -30% | -$25.6M | 0.01% | 835 |
|
|
2019
Q3 | $87.2M | Sell |
573,976
-58,485
| -9% | -$9.25M | 0.01% | 662 |
|
|
2019
Q2 | $96.8M | Buy |
632,461
+51,252
| +9% | +$7.83M | 0.01% | 653 |
|
|
2019
Q1 | $93.3M | Buy |
581,209
+236,723
| +69% | +$36.7M | 0.01% | 658 |
|
|
2018
Q4 | $53.1M | Sell |
344,486
-245,123
| -42% | -$38.2M | 0.01% | 798 |
|
|
2018
Q3 | $88.7M | Sell |
589,609
-3,410
| -0.6% | -$484K | 0.01% | 708 |
|
|
2018
Q2 | $80.2M | Buy |
593,019
+229,136
| +63% | +$28.3M | 0.01% | 732 |
|
|
2018
Q1 | $48.4M | Sell |
363,883
-8,090
| -2% | -$1.09M | 0.01% | 887 |
|
|
2017
Q4 | $55.3M | Buy |
371,973
+78,690
| +27% | +$10.7M | 0.01% | 833 |
|
|
2017
Q3 | $38.7M | Sell |
293,283
-5,072
| -2% | -$682K | 0.01% | 952 |
|
|
2017
Q2 | $39.8M | Buy |
298,355
+6,507
| +2% | +$878K | 0.01% | 919 |
|
|
2017
Q1 | $39.4M | Sell |
291,848
-7,690
| -3% | -$996K | 0.01% | 894 |
|
|
2016
Q4 | $36M | Buy |
299,538
+581
| +0.2% | +$68.5K | 0.01% | 930 |
|
|
2016
Q3 | $37.4M | Sell |
298,957
-389
| -0.1% | -$51K | 0.01% | 907 |
|
|
2016
Q2 | $41.4M | Buy |
299,346
+1,982
| +0.7% | +$257K | 0.01% | 860 |
|
|
2016
Q1 | $37.5M | Sell |
297,364
-37,557
| -11% | -$4.77M | 0.01% | 882 |
|
|
2015
Q4 | $42.5M | Sell |
334,921
-2,935,439
| -90% | -$364M | 0.01% | 822 |
|
|
2015
Q3 | $378M | Sell |
3,270,360
-859,610
| -21% | -$96.5M | 0.08% | 263 |
|
|
2015
Q2 | $430M | Sell |
4,129,970
-17,410
| -0.4% | -$1.88M | 0.09% | 250 |
|
|
2015
Q1 | $458M | Sell |
4,147,380
-306,350
| -7% | -$33.3M | 0.09% | 255 |
|
|
2014
Q4 | $464M | Sell |
4,453,730
-657,670
| -13% | -$65.8M | 0.1% | 243 |
|
|
2014
Q3 | $491M | Sell |
5,111,400
-256,755
| -5% | -$23.2M | 0.11% | 225 |
|
|
2014
Q2 | $491M | Sell |
5,368,155
-633,503
| -11% | -$56.7M | 0.11% | 226 |
|
|
2014
Q1 | $528M | Sell |
6,001,658
-55,410
| -0.9% | -$4.86M | 0.12% | 214 |
|
|
2013
Q4 | $562M | Sell |
6,057,068
-175,210
| -3% | -$15.8M | 0.13% | 191 |
|
|
2013
Q3 | $509M | Buy |
6,232,278
+16,700
| +0.3% | +$1.41M | 0.13% | 209 |
|
|
2013
Q2 | $517M | Buy |
+6,215,578
| New | +$535M | 0.14% | 193 |
|
Other funds holding CLX
VCM
VPM
DAM
T. Rowe Price Associates's CLX Position: Q1 2026 in Review
T. Rowe Price Associates reduced its Clorox (CLX) stake by 2.1% in Q1 2026, selling an estimated $435K and leaving 179,955 shares worth $18.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1063.
T. Rowe Price Associates first reported a position in CLX in Q2 2013 and has held it in 52 quarters since. The position peaked at $562M in Q4 2013. 1,080 funds tracked by Wall St. Rank hold CLX as of Q1 2026.
- T. Rowe Price Associates held 179,955 shares of Clorox worth $18.6M as of Q1 2026.
- T. Rowe Price Associates sold 3,837 Clorox shares in Q1 2026, an estimated $435K.
- Clorox made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #1063 holding.
- T. Rowe Price Associates first reported a position in Clorox in Q2 2013 and has held it in 52 quarters since.
- T. Rowe Price Associates's Clorox position peaked at $562M in Q4 2013.
- 1,080 funds tracked by Wall St. Rank held Clorox as of Q1 2026.
Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.